EC Healthcare (HKG:2138) First Half 2025 Results
Key Financial Results
- Revenue: HK$2.06b (down 2.8% from 1H 2024).
- Net income: HK$14.1m (up 112% from 1H 2024).
- Profit margin: 0.7% (up from 0.3% in 1H 2024).
- EPS: HK$0.012 (up from HK$0.006 in 1H 2024).
All figures shown in the chart above are for the trailing 12 month (TTM) period
EC Healthcare Earnings Insights
Looking ahead, revenue is forecast to grow 8.7% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Consumer Services industry in Hong Kong.
Performance of the Hong Kong Consumer Services industry.
The company's shares are down 2.8% from a week ago.
Risk Analysis
It's still necessary to consider the ever-present spectre of investment risk. We've identified 1 warning sign with EC Healthcare, and understanding this should be part of your investment process.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.